IMMUNOLOGICAL ASPECTS OF EMBRYO DEVELOPMENT
12. Conner SJ, Lefièvre L, Hughes DC et al. Cracking the egg: increased
complexity in the zona pellucida. Hum Reprod 2005; 20: 1148–52.
13. Naz RK, Gupta SK, Gupta JC et al. Recent advances in contraceptive
vaccine development: a mini-review. Hum Reprod 2005; 20: 3271–83.
14. Koyama K, Hasegawa A, Mochida N et al. Follicular dysfunction induced
by autoimmunity to the zona pellucida. Reprod Biol 2005; 5: 269–78.
15. Nottola SA, Makabe S, Stallone T et al. Surface morphology of the
zona pellucida surrounding human blastocysts obtained after in vitro
fertilization. Arch Histol Cytol 2005; 68: 133–41.
16. Cohen J, Inge KL, Suzman M et al. Videocinematography of fresh
and cryopreserved embryos: a retrospective analysis of embryonic
morphology and implantation. Fertil Steril 1989; 52: 877–8.
17. Sun YP, Xu Y, Cao T et al. Zona pellucida thickness and clinical preg-
nancy outcome following in vitro fertilization. Int J Gynaecol Obstet
2005; 89: 258–62.
18. Manniko M,Mormala RM, Tuuri T et al. Association between sequence
variations in genes encoding human zona pellucida glycoproteins and
fertilization failure in IVF. Hum Reprod 2005; 20: 1578–85.
19. Seif M, Edi-Osagie E, Farquhar C et al. Assisted hatching on assisted
conception (IVF & ICSI). Cochrane Database Syst Rev 2006; 1: 1–68.
20. Ewoldsen MA, Ostlie NS, Warner CM. Killing of mouse blastocyst
stage embryos by cytotoxic T lymphocytes directed to major histo-
compatibility complex antigens. J Immunol 1987; 138: 2764–70.
21. Cohen J, Malter H, Elsner C et al. Immunosuppression supports
implantation of zona pellucida dissected human embryos. Fertil Steril
1990; 53: 662–5.
22. Goldbard SB, Gollnick SO, Warner CM. A highly sensitive method
for the detection of cell surface antigens on preimplantation mouse
embryos. J Immunol Meth 1984; 68: 137–46.
23. McElhinny AS, Warner CM. Detection of major histocompatibility
complex class I antigens on the surface of a single murine blastocyst by
Immuno-PCR. BioTechniques 1997; 23: 660–2.
24. Niemeyer CM, Adler M, Wacker R. Immuno-PCR: high sensitivity
detection of proteins by nucleic acid amplification. Trends Biotech
2005; 23: 208–16.
25. Sharov AA, Piao Y, Matoba R et al. Transcriptome analysis of mouse
stem cells and early embryos. PLos Biol 2003; 1: 410–19.
26. Carter MG, Piao Y, Dudekula DB et al. The NIA cDNA project in
mouse stem cells and early embryos. C R Biol 2003; 326: 931–40.
27. Hamatani T, Carter MG, Sharov AA et al. Dynamics of global gene
expression changes during mouse preimplantation development. Dev
Cell 2004; 6: 117–31.
28. Ko MS. Embryogenomics of pre-implantation mammalian develop-
ment: current status. Reprod Fertil Dev 2004; 16: 79–85.
29. Ko MS.Molecular biology of preimplantation embryos: primer for philo-
sophical discussions. Reprod Biomed Online 2005; 10(Suppl 1): 80–87.
30. Margulies DH, McCluskey J. The major histocompatibility complex
and its encoded proteins. In: Paul WE, ed. Fundamental Immunology
5th edn. Philadelphia: Lippincott Williams & Wilkins, 2003: 571–612.
31. Comiskey M, Goldstein CY, De Fazio SR et al. Evidence that HLA-G is
the functional homolog of mouse Qa-2, the Ped gene product. Hum
Immunol 2003; 64: 999–1004.
32. Clements CS, Kjer-Nielsen L, Kostenko L et al. Crystal structure of
HLA-G: a nonclassical MHC class I molecule expressed at the fetal-
maternal interface. Proc Natl Acad Sci USA 2005; 102: 3360–5.
33. Searle RF, Sellens MH, Elson J et al. Detection of alloantigens during
preimplantation development and early trophoblast differentiation.
J Exp Med 1976; 143: 348–59.
34. Warner CM, Spannaus DJ. Demonstration of H-2 antigens on preim-
plantation mouse embryos using conventional antisera and mono-
clonal antibody. J Exp Zool 1984; 230: 37–52.
35. Webb CG, Gall WE,Edelman GM. Synthesis and distribution of H-2 anti-
gens in preimplantation mouse embryos. J Exp Med 1977; 146: 923–31.
36. Krco CJ, Goldberg EM. Major histocompatibility antigens on pre-
implantation mouse embryos. Trans Proc 1977; IX: 1367–70.
37. Cozad KM, Warner CM. Detection of H-2 antigens on 8-cell mouse
embryos. J Exp Zool 1982; 221: 213–17.
38. Tian Z, Xu Y, Warner CM. Removal of Qa-2 antigen alters the Ped gene
phenotype of preimplantation mouse embryos. Biol Reprod 1992; 47:
271–6.
39. Warner CM, Almquist CD, Toulimat MH et al. Induction of embry-
onic major histocompatibility complex antigen expression by ␥-IFN.
J Reprod Immunol 1993; 24: 111–21.
40. Warner CM, Gollnick SO et al. Expression of H-2K major histocom-
patibility antigens on preimplantation mouse embryos. Bio Reprod
1993; 48: 1082–7.
41. McElhinny AS, Kadow N, Warner CM. The expression pattern of the
Qa-2 antigen in mouse preimplantation embryos and its correlation
with the Ped gene phenotype. Mol Hum Reprod 1998; 4: 966–71.
42. Desoye G, Dohr GA, Motter W et al. Lack of HLA class I and class II
antigens on human preimplantation embryos. J Immunol 1988; 140:
4157–9.
43. Roberts JM, Taylor CT, Melling GC et al. Expression of the CD46 anti-
gen, and absence of class I MHC antigen, on the human oocyte and
preimplantation blastocyst. Immunology 1992; 75: 202–5.
44. Manyonda IT. The Immunology of Human Reproduction. London:
Taylor & Francis, 2006: 26–7.
45. Jurisicova A, Casper RF, MacLusky et al. HLA-G expression during
preimplantation human embryo development. Proc Natl Acad Sci USA
1996; 93: 161–5.
46. Drukker M, Katz G, Urbach A et al. Characterization of the expression
of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci
USA 2002; 99: 9864–9.
47. Fuzzi B, Rizzo R, Criscuoli L et al. HLA-G expression in early embryos
is a fundamental prerequisite for the obtainment of pregnancy. Eur J
Immunol 2002; 32: 311–15.
48. Sher G, Keskintepe L, Nouriani M et al. Expression of sHLA-G in
supernatants of individually cultured 46-h embryos: a potentially
valuable indicator of ‘embryo competency’ and IVF outcome. Reprod
Biomed Online 2004; 9: 74–8.
49. Noci I, Fuzzi B, Rizzo R et al. Embryonic soluble HLA-G as a marker
of developmental potential in embryos. Hum Reprod 2005; 20: 138–46.
50. Sher G, Kestintepe L, Batzofin J et al. Influence of early ICSI-derived
embryo sHLA-G expression on pregnancy and implantation rates: a
prospective study. Hum Reprod 2005; 20: 1359–63.
51. Sher G, Kestintepe L, Fisch JD et al. Soluble human leukocyte antigen G
expression in phase I culture media at 46 hours after fertilization pre-
dicts pregnancy and implantation from day 3 embryo transfer. Fertil
Steril 2005; 83: 1410–13.
52. Yie SM, Balakier H, Motamedi G et al. Secretion of human leukocyte
antigen-G by human embryos is associated with a higher in vitro
fertilization pregnancy rate. Fertil Steril 2005; 83: 30–6.
53. Van Lierop MJ, Wijnands F, Loke YW et al. Detection of HLA-G by a
specific sandwich ELISA using monoclonal antibodies G233 and 56B.
Mol Hum Reprod 2002; 8: 776–84.
54. Noriko S, Horotsugu H, Masanori Y et al. Are in vitro fertilized
eggs able to secrete soluble HLA-G? Am J Reprod Immunol 2004; 52
(Suppl 1): P8.
55. Ivell R. Comment from the Editor-in-chief. Mol Hum Reprod 2005;
11: 693.
56. Sargent IL. Does ‘soluble’ HLA-G really exist? Another twist to the tale.
Mol Hum Reprod 2005; 11: 695–8.